Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations. 1982

S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen

The pharmacokinetics of two marketed controlled-release lithium preparations, lithium carbonate ('Priadel') and lithium citrate ('Litarex'), were compared in 5 normal volunteers in a crossover design using identical doses (27.2 mmol lithium). Although the total bioavailability of the two preparations was similar, the peak serum lithium achieved was significantly lower with the lithium citrate than with the lithium carbonate preparation.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D002951 Citrates Derivatives of CITRIC ACID.
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016651 Lithium Carbonate A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard

Related Publications

S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
January 1974, Current medical research and opinion,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
February 1994, American journal of hospital pharmacy,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
October 1992, Biopharmaceutics & drug disposition,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
January 1979, Journal of clinical pharmacology,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
September 1990, The New England journal of medicine,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
April 1989, Journal of clinical pharmacology,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
July 2000, Drug development and industrial pharmacy,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
October 1979, The Medical journal of Australia,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
January 1991, European journal of clinical pharmacology,
S P Tyrer, and M A Peat, and P S Minty, and A Luchini, and V Glud, and A Amdisen
February 1977, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!